Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial

BACKGROUND: Progress in vitrification techniques has allowed reproductive physicians to consider new strategies for using progestin as an alternative to a GnRH analogue to improve in vitro fertilisation (IVF). However, the role of progestin in blocking luteinising hormone (LH) surges and its potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yun, Kuang, Yanping, Chen, Qiuju, Cai, Renfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106816/
https://www.ncbi.nlm.nih.gov/pubmed/30134964
http://dx.doi.org/10.1186/s13063-018-2850-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106816/
https://www.ncbi.nlm.nih.gov/pubmed/30134964
http://dx.doi.org/10.1186/s13063-018-2850-x

Ejemplares similares